MeSH term
Frequency | Condition_Probility | Acute Disease | 2 | 0.0 |
Adult | 5 | 0.0 |
Bone Marrow Transplantation/*statistics & numerical data | 2 | 2.0 |
Comparative Study | 7 | 0.0 |
Cord Blood Stem Cell Transplantation/*statistics & numerical data | 2 | 2.0 |
Fetal Blood/transplantation | 2 | 2.0 |
Humans | 60 | 0.0 |
Leukemia/*therapy | 2 | 1.0 |
Patient Selection | 2 | 1.0 |
Female | 14 | 0.0 |
Middle Aged | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Waardenburg's Syndrome/genetics | 6 | 28.0 |
Animals | 37 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 4 | 1.0 |
*Gene Expression Regulation | 5 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Mutation | 16 | 0.0 |
Promoter Regions (Genetics) | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 48 | 0.0 |
Signal Transduction | 4 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Hela Cells | 4 | 0.0 |
High Mobility Group Proteins/*physiology | 2 | 16.0 |
Point Mutation | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Child, Preschool | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 11 | 0.0 |
High Mobility Group Proteins/*genetics | 11 | 12.0 |
Infant | 2 | 0.0 |
Male | 13 | 0.0 |
*Nerve Growth Factors | 2 | 1.0 |
Nerve Tissue Proteins/*genetics | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Cells, Cultured | 5 | 0.0 |
High Mobility Group Proteins/genetics/*physiology | 3 | 33.0 |
Hirschsprung Disease/genetics | 4 | 25.0 |
In Situ Hybridization | 13 | 0.0 |
Mice | 25 | 0.0 |
Phenotype | 7 | 0.0 |
Crosses, Genetic | 3 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Embryo/metabolism | 2 | 1.0 |
Genetic Vectors | 2 | 0.0 |
Genotype | 4 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Tissue Distribution | 3 | 0.0 |
beta-Galactosidase/metabolism | 2 | 1.0 |
Amino Acid Sequence | 13 | 0.0 |
Base Sequence | 14 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics | 3 | 3.0 |
Genes, Dominant/*genetics | 2 | 2.0 |
High Mobility Group Proteins/chemistry/*genetics | 4 | 30.0 |
Infant, Newborn | 4 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Syndrome | 4 | 0.0 |
Biological Markers | 3 | 0.0 |
Chick Embryo | 6 | 1.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Case-Control Studies | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 5 | 0.0 |
High Mobility Group Proteins/genetics/*metabolism | 4 | 16.0 |
Hirschsprung Disease/*genetics | 10 | 13.0 |
Neuroglia/metabolism | 2 | 2.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Blotting, Western | 5 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mice, Congenic | 2 | 12.0 |
Mice, Inbred C3H | 5 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Pedigree | 4 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Gene Expression Regulation, Developmental | 7 | 0.0 |
Conserved Sequence | 3 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Gene Deletion | 2 | 0.0 |
High Mobility Group Proteins/biosynthesis/*genetics | 3 | 25.0 |
Mice, Mutant Strains | 5 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Transcription Factors/*genetics | 3 | 0.0 |
Transfection | 7 | 0.0 |
Waardenburg's Syndrome/*genetics | 6 | 15.0 |
RNA, Messenger/genetics | 3 | 0.0 |
COS Cells | 4 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Genes, Reporter | 5 | 0.0 |
High Mobility Group Proteins/*genetics/metabolism | 3 | 23.0 |
Trans-Activation (Genetics) | 6 | 0.0 |
3T3 Cells | 2 | 0.0 |
Epistasis, Genetic | 2 | 3.0 |
Frameshift Mutation | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Child | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Transcription Factors/genetics | 4 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Sequence Deletion | 3 | 0.0 |
DNA/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Receptors, Nicotinic/*genetics | 2 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Rats | 8 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Brain/metabolism | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Cell Line | 3 | 0.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Disease Models, Animal | 4 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Nerve Tissue Proteins/metabolism | 2 | 0.0 |
Hypopigmentation/*genetics | 2 | 40.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Exons | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
High Mobility Group Proteins/genetics | 2 | 5.0 |
Apoptosis/physiology | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Melanocytes/*metabolism | 2 | 5.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Transcription Factors/*biosynthesis | 2 | 1.0 |
Cercopithecus aethiops | 2 | 0.0 |
Chondrogenesis/*physiology | 2 | 25.0 |
Oncogene Proteins/*genetics | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
High Mobility Group Proteins/metabolism | 2 | 10.0 |
